DePuy is still in a good place despite recall woes
This article was originally published in Clinica
Executive Summary
Interesting times for the global hip implants sector, and given an extra bit of spice yesterday on the news that UK company Corin will go direct in the US with its Cormet metal on metal (MoM) hip resurfacing system (www.clinica.co.uk, 14 July 2011). Its local deal with Stryker has ended. The Kalamazoo, Michigan company says that changing market opportunities prompted its decision to withdraw from the segment. Hip resurfacing devices will get no more of its attention.
You may also be interested in...
DTx And Drug Deal Sees Closed Loop Medicine And Teva Team Up On Precision Care
Medicines are still typically prescribed based on average effects in a population and rarely dose-optimized for the individual, says Closed Loop Medicine. The company sees a new strategic partnership with Teva UK as another step in advancing personalized medicine.
Swiss-EU Standoff Set To End? Medtechs Eye MRA Action
Negotiations aimed at renewing the close trading relationship and barrier-free mutual market access between Switzerland and the EU got underway on 19 March. Swiss medtech companies welcomed the move, stressing the need for the defunct mutual recognition agreement to be updated.
A Healthtech Global Software Business With A Silicon Valley Look
Royal Philips’ head of Enterprise Informatics Shez Partovi explains the rationale behind the 2023 decision to set up a vertical business for digital, AI and software applications, to operate alongside imaging, monitoring and interventional therapy.